An economic evaluation alongside a randomized controlled trial evaluating an individually tailored lifestyle intervention compared with usual care in people with Familial HypercholesterolemiaReport as inadecuate




An economic evaluation alongside a randomized controlled trial evaluating an individually tailored lifestyle intervention compared with usual care in people with Familial Hypercholesterolemia - Download this document for free, or read online. Document in PDF available to download.

BMC Research Notes

, 8:317

Cardiovascular Disorders

Abstract

BackgroundCost-effectiveness analyses provide insight in the use of lifestyle interventions. To evaluate the cost-effectiveness of a lifestyle intervention compared to usual care in people with Familial Hypercholesterolemia, 340 people with FH were randomized to the intervention or control group. LDL cholesterol, quality of life and costs were measured at 0 and 12 months. Cost-effectiveness analyses were performed from a healthcare perspective using bootstrapping techniques.

ResultsNon-significant decreases in LDL cholesterol and quality of life were found. The mean between-group difference in costs was €−237 95% CI −1,386 to 130. The incremental cost-effectiveness ratios were 1,729 per 1 mmol-l LDL cholesterol and 145,899 per QALY gained. Assumed that the small non-significant decrease in LDL cholesterol is attributed to the intervention, the probability of cost-effectiveness of the intervention compared to usual care was 91% per 1 mmol-l LDL cholesterol reduction and 75% per QALY gained at a ceiling ratio of €20,000.

ConclusionsThe intervention is not cost-effective.

Trial registration: NTR1899, date 07-07-2009.

KeywordsCost-benefit analysis Counselling Cardiovascular disease Cholesterol Sedentary lifestyle AbbreviationsFHFamilial Hypercholesterolemia

LDL-Clow-density lipoprotein cholesterol

CIconfidence interval

QALYquality adjusted life years

DALYdisability adjusted life years

CVDcardiovascular disorders

StOEHStichting Opsporing Erfelijke Hypercholesterolemie

RCTrandomized controlled trial

MImotivational interviewing

BMIbody mass index

ICERincremental cost-effectiveness ratio

CEACcost-effectiveness acceptability curve

CEAcost-effectiveness analysis

Download fulltext PDF



Author: Karen Broekhuizen - Marieke F van Wier - Lando L J Koppes - Johannes Brug - Willem van Mechelen - Judith E Bosmans - Mir

Source: https://link.springer.com/



DOWNLOAD PDF




Related documents